Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Advisors Asset Management Inc.

Advisors Asset Management Inc. lowered its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,313 shares of the biotechnology company’s stock after selling 1,129 shares during the quarter. Advisors Asset Management Inc.’s holdings in Axon Enterprise were worth $17,421,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Geode Capital Management LLC boosted its stake in Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after buying an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP boosted its stake in Axon Enterprise by 12.2% during the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC boosted its stake in Axon Enterprise by 13.9% during the third quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after buying an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Axon Enterprise by 1.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after buying an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment bought a new position in Axon Enterprise during the third quarter valued at about $200,000. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 1,035 shares of the business’s stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total transaction of $646,326.45. Following the sale, the insider now directly owns 124,243 shares in the company, valued at approximately $77,586,026.21. The trade was a 0.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

AXON has been the subject of a number of recent analyst reports. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. Robert W. Baird increased their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $604.67.

Axon Enterprise Stock Down 0.3 %

AXON opened at $554.82 on Tuesday. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99. The firm has a market cap of $42.51 billion, a P/E ratio of 143.36, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The business has a 50 day moving average price of $593.10 and a 200 day moving average price of $538.04. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.